AnalysisNews

OFIX today

$6.94-$0.24 (-3.34%)close Nov 12, 2026

Trend

DailyUptrend (confirmed)

4 hourLeaning Bearish

1 hourSymmetric Triangle

15 minLeaning Bullish

5 minStrong Bearish

Daily trend turns down below $9.64

Key levels

Resistance$9.28

Resistance$8.55

Latest news & SEC filings

SEC FilingOrthofix Medical Inc. filed an insider trading report (Form 4)

EarningsOrthofix Medical holds Q3 2026 earnings call

All OFIX news →

About Orthofix

Orthofix is a medical technology company focused on treating musculoskeletal conditions. Its Global Spine unit sells spinal implants, bone-healing therapies, biologic grafts, and image-guided surgical navigation equipment, while its Global Limb Reconstruction unit offers products for rebuilding damaged limbs. The company reaches surgeons and care facilities in the United States and other countries through its own sales teams and independent distributors.

Based on the company's 10-K filed Feb 24, 2026.

Nasdaq · Healthcare

Orthofix Medical Inc. (OFIX)

$6.94-0.24 (-3.34%)
WATCHLISTGrade: B+Risk: MEDIUM
1D5D1M1Y5YMaxSign up for all timeframes
7.608.268.929.586.94Oct 12Oct 20Oct 28Nov 5
High7.39
Low6.83
Open7.20
Volume528K
Avg Vol539K
VWAP6.99
30d High10.24
30d Low6.94
30d Chg-23.65%

What Is the Price Target for OFIX?

SEPT Low Target

$13.00

SEPT Mid Target

$15.00

SEPT High Target

$15.00

Analyst Consensus

$15.00

Current: $7.18Upside: +108.9%Confidence: 65%Method: Analyst Consensus

Is OFIX a Buy or Sell Right Now?

71
Investability Score
WATCHLIST12-18 months
News summary · last 30 days
Nov 9▲ UpEarnings5 articles
Orthofix Medical shares surged 12.70% to close at $7.90 after the company reported third-quarter 2026 adjusted earnings of $0.18 per share, well above the $(0.27) forecast. However, revenue of $207.862 million missed the $210.516 million estimate, and the company cut its full-year 2026 sales outlook to $825M-$830M from a prior $845M-$855M range, with the new midpoint below the $851.203 million analyst estimate. The stock traded in a wide range of $6.52 to $8.03 on heavy volume of over 2.68 million shares, as investors weighed the earnings beat against the reduced guidance. The strong bottom-line beat and the 8-K filing on a major company event appear to have driven the bullish price action despite the softer top-line outlook.
Critical news
Nov 9HIGHEarnings: growth/beat

Thesis

  • •Revenue growing 2.9% YoY with STRONG trend — consistent growth.

AI-Powered Trading Signals

Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for OFIX.

Start Free Trial →

Is OFIX Overvalued or Undervalued?

Valuation Verdict

UNDERVALUED

Methods Used

P/B, Analyst Consensus

Fair Value

$17.70

40

Moat Score

NARROW

5/9

Piotroski Score

0.9

Altman Z-Score

What Is Smart Money Doing with OFIX?

Insider Signal

NEUTRAL

4 buys / 7 sells (90d)

Congress Signal

NEUTRAL

0 buys / 0 sells (90d)

Institutional

N/A

Short Squeeze Risk

HIGH

Signal: HIGH_SHORT_INTEREST

Recent Insider Activity

NameTitleTypeSharesValueDate
Juniper Investment Company, LLC10% ownerBuy14,803$104KNov 11, 2026
Juniper Investment Company, LLC10% ownerBuy675,000$5.0MNov 9, 2026
Fisher PatrickofficerSale150$1KNov 2, 2026
Fisher PatrickofficerSale150$1KOct 1, 2026
Juniper Investment Company, LLC10% ownerBuy190,000$1.7MSep 21, 2026
Juniper Investment Company, LLC10% ownerBuy190,000$1.7MSep 21, 2026
Juniper Investment Company, LLC10% ownerBuy120,000$1.0MSep 18, 2026
Juniper Investment Company, LLC10% ownerBuy120,000$1.0MSep 18, 2026
Bazaar Alan LeedirectorBuy14,965-Jun 10, 2026
Kummeth Charles R.directorBuy14,965-Jun 10, 2026

Track Smart Money Across 4,000+ Stocks

Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.

See All Smart Money Signals →

OFIX Growth Story

Revenue YoY

2.9%

3yr Revenue CAGR

21.3%

EPS Growth YoY

29.39%

FCF Growth YoY

85.9%

Revenue Trend

STRONG

Dark Pool Trades for OFIX

PREVIEW

SEPT Investing tracks real-time dark pool institutional trades for OFIX, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.

TimePriceSizeValueSide
21:00:28$6.941,452$$10KSELL
21:00:28$6.942,652$$18KSELL
21:00:28$6.941,900$$13KSELL
21:00:28$6.941,470$$10KSELL
21:00:00$6.941,766$$12KSELL

5 dark pool trades shown · $$64K preview volume

Real-time institutional flow, block trades, and net positioning

See all dark pool activity

Full AI Research Report

SEPT's Trading AI has generated a free, downloadable PDF research report for Orthofix Medical Inc. (OFIX) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.

Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (5 articles analyzed), and SEC filing intelligence...

AI-Powered Trading Signals.

Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.

Try SEPT Free for 7 Days →

OFIX — frequently asked questions

What is OFIX stock price today?

Orthofix Medical Inc. (OFIX) is at $6.94, down 3.34% (-$0.24) at the Nov 12, 2026 close.

Why is OFIX stock moving today?

Latest OFIX news — Nov 12, 2026: Orthofix Medical Inc. filed an insider trading report (Form 4) · Nov 9, 2026: Orthofix Medical holds Q3 2026 earnings call

Why did OFIX stock move on Nov 9, 2026?

Orthofix Medical shares surged 12.70% to close at $7.90 after the company reported third-quarter 2026 adjusted earnings of $0.18 per share, well above the $(0.27) forecast. However, revenue of $207.862 million missed the $210.516 million estimate, and the company cut its full-year 2026 sales outlook to $825M-$830M from a prior $845M-$855M range, with the new midpoint below the $851.203 million analyst estimate.

What is the OFIX price target?

The average analyst price target for OFIX is $15.00, ranging from $13 to $15, based on 3 analysts. Latest: Canaccord Genuity maintains on Aug 10, 2026.

What do analysts rate OFIX?

Analyst ratings for OFIX: 0 Buy, 4 Hold, 0 Sell — consensus Hold.

Did OFIX beat earnings?

OFIX last reported on Nov 9, 2026: EPS $0.18 vs -$0.27 expected — a beat of 166.7%.

Does OFIX pay a dividend?

OFIX does not currently pay a dividend.

What are OFIX support and resistance levels?

Resistance: $8.55, $9.28, $10.04.

What are insiders doing with OFIX?

Insider activity: NEUTRAL, 4 buys and 7 sells in the last 90 days.

What is the latest news on OFIX?

Nov 12, 2026: Orthofix Medical Inc. filed an insider trading report (Form 4) · Nov 9, 2026: Orthofix Medical holds Q3 2026 earnings call